Jyong Biotech Ltd. (MENS) stock
MENSNasdaqPharmaceutical Preparations
$1.86+0.06 (+3.33%)
Close on Nov 18, 2026Market cap $141.41MP/E –Yield –
Jyong Biotech r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was $813.00K, down 12.3% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $813.00K | -12.3% |
| FY2024 | Dec 31, 2024 | $927.00K | -13.4% |
| FY2023 | Dec 31, 2023 | $1.07M | – |
See a number that looks wrong?